The first steps of any journey include choosing the smartest route to your destination.
Going from new molecular entity to drug treatment opportunity is more than a goal, it’s a journey. It’s a complex trek that starts with evidence-based valuations to predict a drug’s efficacy, regulatory acceptance, market potential, licensing impact and more. When you carefully map out the route that lies ahead of you, and have the decision-support technologies to clear obstacles, prospects for success increase greatly. PAREXEL brings together the best minds, processes, and technologies to take you through every phase of development more successfully, including getting you off to a strong start.